Join

Compare · CNMD vs CV

CNMD vs CV

Side-by-side comparison of CONMED Corporation (CNMD) and CapsoVision Inc. (CV): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CNMD and CV operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • CNMD is the larger of the two at $1.16B, about 3.8x CV ($302.5M).
  • Over the past year, CNMD is down 24.5% and CV is up 51.0% - CV leads by 75.5 points.
  • Both names hit the wire about 2 times in the past 4 weeks.
  • CNMD has more recent analyst coverage (14 ratings vs 2 for CV).
PerformanceCNMD-29.15%CV+51.00%
2025-07-02+0.00%2026-04-24
MetricCNMDCV
Company
CONMED Corporation
CapsoVision Inc.
Price
$38.41+2.52%
$6.05+5.03%
Market cap
$1.16B
$302.5M
1M return
+3.74%
-27.49%
1Y return
-24.48%
+51.00%
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NYSE
NASDAQ
IPO
1987
2025
News (4w)
2
2
Recent ratings
14
2
CNMD

CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.